Shares of Biohaven Pharmaceuticals(NYSE:BHVN)are down 15% in premarket trading apparently because some investors are disappointed that a Pfizer(NYSE:PFE)deal to commercialize Nurtec ODT wasn't a ...
网页链接Shares of Biohaven Pharmaceuticals(NYSE:BHVN)are down 15% in premarket trading apparently because some investors are disappointed that a Pfizer(NYSE:PFE)deal to commercialize Nurtec ODT wasn't a ...
网页链接
精彩评论